ADMA Biologics, Inc.
ADMA Biologics, Inc.（ADMA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
adma · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$24.00
Consensus
$21.00
+163.5% upside
Low
$18.00
Median: $21 · Last Close: $7.97
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$21.00
163.5% upside
High Target
$24
201.1%
Low Target
$18
125.8%
Current Price
$7.97
as of today
Based on analyst price targets, the ADMA stock price prediction for the next 12 months ranges from $18 to $24. The consensus ADMA price forecast of $21.00 implies 163.5% upside from the current price of $7.97.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.71 | ↓ 3.27% |
1-day model range: $7.64–$7.78. Peak: $7.78 (-3.27%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $11 | +39.5% |
| 2028 | $14 | +69.7% |
| 2029 | $15 | +90.0% |
| 2030 | $16 | +102.5% |
| 2031 | — | +109.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADMA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-07 | Mizuho | Maintains | Outperform→Outperform |
| 2026-04-13 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-26 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2025-05-08 | Raymond James | Maintains | Strong Buy→Strong Buy |
| 2025-03-04 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-08 | Raymond James | Maintains | Strong Buy→Strong Buy |
| 2024-10-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-20 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on ADMA Biologics, Inc. (ADMA) stock. Of the recent 58 rating actions, 3 were upgrades and 4 were downgrades. 10 analysts currently cover ADMA.
分析师推荐趋势
ADMA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$570M
↓ 30.8% YoY
Revenue Next Year
$689M
↑ 20.9% YoY
EPS This Year
$0.84
EPS Next Year
$1.08
↑ 28.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADMA EPS of $0.84 for the current fiscal year, based on estimates from 2 analysts. The ADMA revenue forecast is $570M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ADMA 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ADMA 的共识目标价为 $21.00（+163.5% 上行空间），分析师共识为 Buy。
ADMA 的短期预测（明日）为 $7.71（-3.27%）。 ADMA 对 2027 年的股价预测均值为 $11。 ADMA 对 2030 年的预测区间为 $15–$17。
ADMA Biologics, Inc. 在 NASDAQ 上市，代码 ADMA。ADMA 在 2027 年的整体展望偏积极，在覆盖分析师中约 90% 对应 Buy 共识。
常见问题
ADMA 预测 · 8 个问题根据 10 位华尔街分析师，ADMA 的 12 个月平均目标价为 $21.00，最高 $24.00、最低 $18.00。若有图表，中位目标价可在上方查看。相对当前价 $7.97，隐含约 +163.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.